The Alzheimer's Drug Discovery Foundation and The Michael J. Fox Foundation Launch $5 Million Partnership to Target Key Co-Pathologies Driving Alzheimer's and Parkinson's
The collaboration will accelerate scalable, minimally invasive biomarkers, continuing momentum toward precision medicine NEW YORK, July 13, 2026 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) today...
The collaboration will accelerate scalable, minimally invasive biomarkers, continuing momentum toward precision medicine NEW YORK, July 13, 2026 /PRNewswire/ -- The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) and The Michael J. Fox Foundation (MJFF) today...
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.